Fierce Biotech1 min read
saveChutes & Ladders—Teva loses R&D head as innovation pivot advances
Teva’s R&D chief has resigned a week after the company's R&D day. The White House yanked its FDA commissioner nomination at the 11th hour. Quanterix restarted its search for a CEO.
And more.
comments(0)
5-min edit window · permanent after that